About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Advanced Diffusion Tensor MRI for Breast Cancer | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT04774471

Advanced Diffusion Tensor MRI for Breast Cancer

The purpose of this research is to evaluate the accuracy of the BIT-Motion (Breast Imaging Tensor-Motion) software with non-contrast MRI scanning to detect breast cancer.

Lead sponsor: Endeavor Health•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Endeavor Health

The goal of this study is to answer the question: what is the ability of the BIT-Motion (Breast Imaging Tensor-Motion) software to detect and discriminate between benign and malignant breast lesions that are identified on mammogram (MG) and ultrasound (US) examinations. Women over the age of 18 who have a breast lesion that is seen on MG or US will be eligible to enroll. Participation in this study will involve one non-invasive non-contrast MRI scan of the breasts.

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Female
•scheduled for ultrasound or stereotactic guided breast biopsy
•\> 18 years of age
•able to tolerate up to 90 minutes in the MRI scanner

Exclusion Criteria

•Male
•Has a medical condition that, in the opinion of the investigator, puts the subject at significant risk
•Has any contraindication to the MRI examination as determined by standard NorthShore University Health System relative to MRI safety
•Cannot comprehend or complete the Informed Consent Form

Related studies

Exercise in Metastatic Breast Cancer: EMBody

NCT05468034 · Breast Cancer, Indolent Metastatic Breast Cancer

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

NCT04541381 · Gastrointestinal Cancer, Head and Neck Cancer, and more

Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI

NCT03137095 · Cancer Related Cognitive Difficulties, Breast Cancer Female

RECRUITINGPhase 3

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

NCT04852887 · Stage I Breast Cancer

Preoperative Sleep Quality and Postoperative Outcomes in Breast Surgery

NCT07547774 · Breast Cancer, Postoperative Pain, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 3, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment68

Start dateFeb 2021

Last updatedJun 3, 2025

Condition

Breast Cancer Breast Diseases

Locations shown

NorthShore University Health System

Evanston, Illinois

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 3, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions